Catalyst Pharmaceuticals is a top ten ranking company because it is a dedicated biopharmaceutical firm creating its niche in ultra-rare and rare diseases. Catalyst’s lead drug, amifampridine, also branded as Firdapse which is LEMS’s only FDA-approved treatment after decades, characterizes its commitment to rare patients. Amifampridine shows meaningful results in prolonged clinic more...

Catalyst Pharmaceuticals is a top ten ranking company because it is a dedicated biopharmaceutical firm creating its niche in ultra-rare and rare diseases. Catalyst’s lead drug, amifampridine, also branded as Firdapse which is LEMS’s only FDA-approved treatment after decades, characterizes its commitment to rare patients. Amifampridine shows meaningful results in prolonged clinical trials. Catalyst believes that integrity, passion, and trust are deeply committed core values. Furthermore, the company’s testimonials empower its patients to showcase their work. Catalyst's products and services are life-transforming for LEMS. These facts are essential when selecting the needed treatment options.

BioLabs@NYULangone is a top 10 co-working space due to its superior facilities, business support, and community atmosphere that fosters success in life science startups. The lab includes state-of-the-art equipment, friendly and attentive staff, and a supportive workplace culture. Participants mentioned positive experiences with the BioLabs team, who are dedicated to helping star more...

BioLabs@NYULangone is a top 10 co-working space due to its superior facilities, business support, and community atmosphere that fosters success in life science startups. The lab includes state-of-the-art equipment, friendly and attentive staff, and a supportive workplace culture. Participants mentioned positive experiences with the BioLabs team, who are dedicated to helping startups grow and succeed. The events and social engagements, organized by Clive and Tina, create a strong sense of community and networking. A convenient location and a wealth of resources also make BioLabs@NYULangone NYC's leading life science co-working space.

Our bold group of entrepreneurs and innovators hails from around the world. We are a diverse group of people who bring different perspectives and skills together. The platform technology that transforms allogeneic tissue therapies is a combination of our bioprinting technology and biomaterials. Diversity is a driving force behind innovative ideas and will ultimately transform h more...

Our bold group of entrepreneurs and innovators hails from around the world. We are a diverse group of people who bring different perspectives and skills together. The platform technology that transforms allogeneic tissue therapies is a combination of our bioprinting technology and biomaterials. Diversity is a driving force behind innovative ideas and will ultimately transform health. Our passion is to collaborate with industry and researchers around the globe in order to expand our technology's capabilities and have a positive impact. Bioprinted tissue therapeutics are bioprinted tissues that can replace damaged or destroyed organ function and transform the way we treat diseases.

Qu Biologics was established in 2007 by Dr. Hal Gunn, a physician and Rob Freeman (a cancer survivor). It was founded with the vision of developing treatments to restore health and normalize immune function. Today, this vision guides us. Qu Biologics Site Specific Immunomodulators are used to activate activated innate immunity cell recruitment to target organs or tissues to trea more...

Qu Biologics was established in 2007 by Dr. Hal Gunn, a physician and Rob Freeman (a cancer survivor). It was founded with the vision of developing treatments to restore health and normalize immune function. Today, this vision guides us. Qu Biologics Site Specific Immunomodulators are used to activate activated innate immunity cell recruitment to target organs or tissues to treat a variety of chronic diseases including cancer, inflammatory bowel disease and other conditions. Hal Gunn's interest in the immune system and how it supports healing has been a part of his life. In 1997, he co-founded InspireHeath (www.inspirehealth.ca), Canada's leading supportive oncology centres, where nutritionists, exercise therapists, counselors and physicians support the health and immune system function of people with cancer during and after cancer treatment. Rob Freeman met Dr. Gunn at InspireHealth. Qu Biologics was founded in 2007. Since then, the company has created four targeted SSIs and treated over 270 cancer patients in compassionate use programs. Qu Biologics also raised more than CAD$40million in private funding and multiple Phase 2 clinical trials for inflammatory bowel disease and cancer. Qu's current focus is on the advancement of QBECO in IBD treatment and cancer.

Fortress Biotech, Inc., is a biopharmaceutical firm that focuses on in-licensing, developing and marketing high-potential drugs. Our company develops and markets products through partnerships. Our partner companies have more than 30 pre-clinical programs1 and clinical trials. These projects cover a wide range of large-market sectors, such as oncology and rare diseases, and allo more...

Fortress Biotech, Inc., is a biopharmaceutical firm that focuses on in-licensing, developing and marketing high-potential drugs. Our company develops and markets products through partnerships. Our partner companies have more than 30 pre-clinical programs1 and clinical trials. These projects cover a wide range of large-market sectors, such as oncology and rare diseases, and allow us to generate shareholder value. The business development team is renowned for their ability to leverage our extensive biopharmaceutical industry knowledge in order to expand the opportunities we have. Some of the most prestigious biopharmaceutical and academic companies in the world have formed partnerships. To maximize every opportunity, we aim to expand and enhance our product range.

Aldevron has been a pioneer in the advancement of biological science. Aldevron's custom development and manufacturing capabilities have enabled scientists all over the globe to access the necessary components for faster research, and opened up laboratories around the world for new science and groundbreaking discoveries. Our mission is to make meaningful contributions in biol more...

Aldevron has been a pioneer in the advancement of biological science. Aldevron's custom development and manufacturing capabilities have enabled scientists all over the globe to access the necessary components for faster research, and opened up laboratories around the world for new science and groundbreaking discoveries. Our mission is to make meaningful contributions in biological science around the world through products and services. Our goal is to become the preferred partner for high-quality plasmid, protein, and enzymes as well as other biologicals that support our clients' broad objectives. Aldevron believes that people are the most important asset. Our goal is to advance science in meaningful ways. We need forward-thinking, dedicated individuals. Find out more information about our current career opportunities. Are you interested in joining our team or would like to know more about our products? Contact our Client Relations team for more information about the services we provide and to start your next project.

Inspirna, a biopharmaceutical company in clinical stage, is developing novel drugs to target cancer-related pathways. Inspire cancer medicine through RNA biology. The team is comprised of drug developers who are experts in developing innovative drugs that treat difficult-to-treat types of cancer. We are using a new discovery platform called RNA-DRIVEr (tm) developed by Inspirna more...

Inspirna, a biopharmaceutical company in clinical stage, is developing novel drugs to target cancer-related pathways. Inspire cancer medicine through RNA biology. The team is comprised of drug developers who are experts in developing innovative drugs that treat difficult-to-treat types of cancer. We are using a new discovery platform called RNA-DRIVEr (tm) developed by Inspirna’s founder scientists at Rockefeller University and exclusively licensed to Inspirna. This allows us to develop first-in class small molecule therapeutics and biologic therapies that target high-unmet cancer driver settings.